
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Clinical decision support for frontotemporal dementia diagnosis, behavioral variant, primary progressive aphasia variants, symptomatic management, and genetic evaluation">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/frontotemporal-dementia/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Frontotemporal Dementia - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#frontotemporal-dementia" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Frontotemporal Dementia
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Headache
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Headache
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/migraine/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Migraine
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_11" >
        
          
          <label class="md-nav__link" for="__nav_3_11" id="__nav_3_11_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Movement Disorders
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_11_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_11">
            <span class="md-nav__icon md-icon"></span>
            
  
    Movement Disorders
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/parkinsons-disease-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Parkinson's Disease - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/essential-tremor/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Essential Tremor
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_12" >
        
          
          <label class="md-nav__link" for="__nav_3_12" id="__nav_3_12_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Dementia & Cognitive
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_12_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_12">
            <span class="md-nav__icon md-icon"></span>
            
  
    Dementia & Cognitive
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/dementia-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Dementia Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_13" >
        
          
          <label class="md-nav__link" for="__nav_3_13" id="__nav_3_13_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Cranial Neuropathies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_13_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_13">
            <span class="md-nav__icon md-icon"></span>
            
  
    Cranial Neuropathies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bells-palsy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bell's Palsy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_14" >
        
          
          <label class="md-nav__link" for="__nav_3_14" id="__nav_3_14_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_14_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_14">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#section-a-action-items" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION A: ACTION ITEMS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#section-b-reference" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION B: REFERENCE
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-ftd-clinical-variants" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: FTD Clinical Variants
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-genetic-evaluation-guide" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Genetic Evaluation Guide
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-c-safety-and-supervision-planning-checklist" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX C: Safety and Supervision Planning Checklist
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:behavioral" class="md-tag">behavioral</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:cognitive" class="md-tag">cognitive</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:dementia" class="md-tag">dementia</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:ftd" class="md-tag">ftd</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:neurodegenerative" class="md-tag">neurodegenerative</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:outpatient" class="md-tag">outpatient</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="frontotemporal-dementia">Frontotemporal Dementia<a class="headerlink" href="#frontotemporal-dementia" title="Permanent link">&para;</a></h1>
<p><strong>DIAGNOSIS:</strong> Frontotemporal Dementia (FTD)
<strong>ICD-10:</strong> G31.09 (Frontotemporal dementia, unspecified); G31.0 (Frontotemporal dementia); F02.80 (Dementia in FTD without behavioral disturbance); F02.81 (Dementia in FTD with behavioral disturbance); G31.01 (Pick's disease)
<strong>SCOPE:</strong> Diagnosis and management of frontotemporal lobar degeneration syndromes including behavioral variant FTD (bvFTD), semantic variant primary progressive aphasia (svPPA), nonfluent/agrammatic variant PPA (nfvPPA), FTD with motor neuron disease (FTD-ALS), and genetic forms (C9orf72, MAPT, GRN). Covers diagnostic evaluation, symptomatic treatment, behavioral management, genetic counseling, safety planning, and caregiver support. Primarily outpatient-focused with coverage for ED and hospital presentations of behavioral crises.</p>
<p><strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<hr />
<h2 id="section-a-action-items">SECTION A: ACTION ITEMS<a class="headerlink" href="#section-a-action-items" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs-reversible-causes-screen">1A. Essential/Core Labs (Reversible Causes Screen)<a class="headerlink" href="#1a-essentialcore-labs-reversible-causes-screen" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBC with differential</td>
<td>Rule out infection, anemia, malignancy contributing to behavioral changes</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>BMP (Na, K, BUN, Cr, glucose)</td>
<td>Metabolic causes of behavioral disturbance (hyponatremia, uremia, hypoglycemia)</td>
<td>Normal electrolytes, renal function</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TSH</td>
<td>Hypothyroidism can cause apathy; hyperthyroidism can cause behavioral changes</td>
<td>0.4-4.0 mIU/L</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin B12</td>
<td>B12 deficiency causes neuropsychiatric symptoms and cognitive decline</td>
<td>&gt;300 pg/mL (&gt;400 optimal)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Folate</td>
<td>Deficiency contributes to cognitive impairment</td>
<td>&gt;3 ng/mL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hepatic panel (AST, ALT, albumin, ammonia)</td>
<td>Hepatic encephalopathy; nutritional status; liver function for medications</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Calcium</td>
<td>Hypercalcemia causes neuropsychiatric symptoms</td>
<td>8.5-10.5 mg/dL</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Urinalysis</td>
<td>UTI common cause of acute behavioral changes in elderly</td>
<td>Negative for infection</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>RPR or VDRL</td>
<td>Neurosyphilis is treatable cause of behavioral and cognitive changes</td>
<td>Nonreactive</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HIV testing</td>
<td>HIV-associated neurocognitive disorder if risk factors</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ESR, CRP</td>
<td>Inflammatory or autoimmune causes; baseline before immunotherapy</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ANA, RF</td>
<td>Screen for systemic autoimmune disease</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Creatine kinase</td>
<td>Elevated in FTD-ALS; baseline for motor neuron involvement</td>
<td>Normal (elevated suggests MND)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>EMG/NCS referral</td>
<td>If motor symptoms present; evaluate for ALS overlap</td>
<td>Normal or denervation pattern</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Serum progranulin level</td>
<td>Low levels suggest GRN mutation (screening test)</td>
<td>Normal (low &lt;100 ng/mL suggests GRN mutation)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-genetic-and-atypical-evaluation">1C. Rare/Specialized (Genetic and Atypical Evaluation)<a class="headerlink" href="#1c-rarespecialized-genetic-and-atypical-evaluation" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>C9orf72 hexanucleotide repeat expansion</td>
<td>Most common genetic cause of FTD; also causes ALS</td>
<td>&lt;30 repeats (pathogenic &gt;30)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MAPT (tau) gene sequencing</td>
<td>Familial FTD with parkinsonism; tau-positive pathology</td>
<td>No pathogenic mutation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>GRN (progranulin) gene sequencing</td>
<td>Familial FTD; asymmetric atrophy; TDP-43 pathology</td>
<td>No pathogenic mutation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>FTD genetic panel (TARDBP, VCP, CHMP2B, FUS)</td>
<td>Extended genetic evaluation if first-line negative</td>
<td>No pathogenic mutation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Paraneoplastic antibody panel</td>
<td>Rapid behavioral change; history of cancer; atypical features</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GAD65)</td>
<td>Autoimmune encephalitis mimicking FTD</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Heavy metal panel (lead, mercury, arsenic)</td>
<td>Occupational exposure history; atypical presentation</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain without contrast</td>
<td>At initial evaluation</td>
<td>Frontal and/or anterior temporal atrophy; asymmetric patterns; rule out structural causes</td>
<td>MRI-incompatible devices, severe claustrophobia</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CT Head non-contrast</td>
<td>If MRI unavailable or contraindicated</td>
<td>Rule out mass, hemorrhage, hydrocephalus; frontal atrophy visible</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>FDG-PET Brain</td>
<td>Diagnostic confirmation; differentiate from AD</td>
<td>Frontal and/or anterior temporal hypometabolism; sparing of posterior parietal (unlike AD)</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRI Brain volumetrics</td>
<td>Quantify regional atrophy; track progression</td>
<td>Frontal/temporal volume loss; hemispheric asymmetry</td>
<td>MRI contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Amyloid PET</td>
<td>Exclude AD pathology if clinical uncertainty</td>
<td>Negative amyloid supports FTD diagnosis</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>EEG</td>
<td>Seizures; behavioral episodes; differentiate from CJD</td>
<td>Usually normal or mild slowing; no periodic discharges (CJD has)</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sleep study (polysomnography)</td>
<td>RBD suggests DLB rather than FTD; sleep disturbance common</td>
<td>REM without atonia absent (if RBD, reconsider DLB)</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>DaTscan (ioflupane I-123)</td>
<td>Parkinsonism present; differentiate PSP/CBD from PD/DLB</td>
<td>Reduced uptake in PSP/CBD; may be normal early in bvFTD</td>
<td>Iodine hypersensitivity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Tau PET (flortaucipir)</td>
<td>Research; distinguish tau-positive from TDP-43 FTD</td>
<td>Tau-positive FTD shows frontal/temporal uptake</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Whole body PET-CT</td>
<td>Paraneoplastic workup if suspected</td>
<td>Rule out occult malignancy</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h3 id="lumbar-puncture">LUMBAR PUNCTURE<a class="headerlink" href="#lumbar-puncture" title="Permanent link">&para;</a></h3>
<p><strong>Indication:</strong> Exclude other causes (infection, inflammation, CJD); biomarker support for diagnosis; CSF NfL for prognosis
<strong>Timing:</strong> ROUTINE for diagnostic evaluation; URGENT if autoimmune or infectious etiology suspected
<strong>Volume Required:</strong> 10-15 mL standard; additional for research biomarkers</p>
<table>
<thead>
<tr>
<th>Study</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cell count, protein, glucose</td>
<td>Rule out infection, inflammation</td>
<td>WBC &lt;5, protein &lt;45 mg/dL, glucose &gt;60% serum</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF Aβ42/Aβ40 ratio</td>
<td>Distinguish from AD (normal in FTD)</td>
<td>Normal ratio &gt;0.08 supports non-AD etiology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF total tau (t-tau)</td>
<td>Non-specific neurodegeneration marker</td>
<td>May be elevated but less than AD</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF phosphorylated tau (p-tau181)</td>
<td>AD-specific; should be normal in FTD</td>
<td>Normal p-tau supports FTD over AD</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF NfL (neurofilament light)</td>
<td>Neurodegeneration marker; prognostic; very high in ALS-FTD</td>
<td>Elevated (higher = faster progression)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>14-3-3 protein</td>
<td>Rapid progression; rule out CJD</td>
<td>Negative (positive suggests CJD)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>RT-QuIC</td>
<td>Prion disease confirmation if suspected</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Autoimmune encephalitis panel (CSF)</td>
<td>Subacute behavioral change; seizures</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>Special Handling:</strong> CSF biomarkers require polypropylene tubes; freeze within 1 hour; send to qualified reference lab
<strong>Contraindications:</strong> Coagulopathy (INR &gt;1.5, platelets &lt;50k); posterior fossa mass; skin infection at puncture site</p>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<p><strong>CRITICAL NOTE:</strong> No FDA-approved disease-modifying treatments exist for FTD. Treatment is symptomatic and supportive. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are NOT recommended and may worsen behavioral symptoms.</p>
<h3 id="3a-acuteemergent-behavioral-crisis-management">3A. Acute/Emergent (Behavioral Crisis Management)<a class="headerlink" href="#3a-acuteemergent-behavioral-crisis-management" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lorazepam</td>
<td>PO/IM/IV</td>
<td>Acute severe agitation when de-escalation fails</td>
<td>0.5 mg PO; 1 mg PO; 0.5 mg IM; 1 mg IM :: PO/IM/IV :: :: 0.5-1 mg PO or IM; may repeat q30min PRN; max 4 mg; short-term use only</td>
<td>Respiratory depression; severe hepatic impairment; paradoxical agitation risk in elderly</td>
<td>Respiratory status; sedation; paradoxical reactions</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Haloperidol</td>
<td>IM/IV</td>
<td>Severe aggression/psychosis when benzodiazepines insufficient</td>
<td>0.5 mg IM; 1 mg IM; 2 mg IM :: IM/IV :: :: 0.5-2 mg IM q4-6h PRN; lowest effective dose; short-term crisis only</td>
<td>QT prolongation; Parkinson's disease; FTD-parkinsonism overlap (avoid if possible)</td>
<td>QTc; EPS; akathisia; sedation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Environmental de-escalation</td>
<td>N/A</td>
<td>First-line for all behavioral disturbance</td>
<td>N/A :: N/A :: :: Reduce stimulation; dim lights; calm voice; remove triggers; one-to-one observation; familiar caregiver presence</td>
<td>None</td>
<td>Response to intervention</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3b-symptomatic-treatments-behavioral-and-neuropsychiatric">3B. Symptomatic Treatments (Behavioral and Neuropsychiatric)<a class="headerlink" href="#3b-symptomatic-treatments-behavioral-and-neuropsychiatric" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Trazodone</td>
<td>PO</td>
<td>Agitation; irritability; disinhibition; insomnia; compulsive behaviors</td>
<td>25 mg BID; 50 mg BID; 50 mg TID; 100 mg TID :: PO :: :: Start 25-50 mg BID; titrate by 25-50 mg q3-5d; typical 150-300 mg/day divided; max 400 mg/day</td>
<td>Concurrent MAOIs; significant QT prolongation</td>
<td>Orthostatic hypotension (fall risk); priapism (rare); QTc; sedation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sertraline (Zoloft)</td>
<td>PO</td>
<td>Depression; apathy; anxiety; compulsive behaviors; disinhibition</td>
<td>25 mg daily; 50 mg daily; 100 mg daily; 150 mg daily :: PO :: :: Start 25 mg daily; increase by 25-50 mg every 1-2 weeks; typical 100-200 mg daily; max 200 mg</td>
<td>MAOIs; uncontrolled seizures (lowers threshold slightly)</td>
<td>GI symptoms; bleeding risk; apathy (rarely worsens)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Citalopram</td>
<td>PO</td>
<td>Depression; anxiety; compulsive behaviors</td>
<td>10 mg daily; 20 mg daily :: PO :: :: Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk</td>
<td>QT prolongation; concurrent QT-prolonging drugs; severe hepatic impairment</td>
<td>ECG at baseline if cardiac risk; QTc monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Escitalopram (Lexapro)</td>
<td>PO</td>
<td>Depression; anxiety; better tolerated than citalopram</td>
<td>5 mg daily; 10 mg daily :: PO :: :: Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly</td>
<td>QT prolongation; concurrent MAOIs</td>
<td>QTc if cardiac risk factors</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fluvoxamine</td>
<td>PO</td>
<td>Compulsive behaviors; repetitive behaviors; may have specific benefit in FTD</td>
<td>25 mg qHS; 50 mg qHS; 100 mg qHS; 100 mg BID :: PO :: :: Start 25 mg qHS; titrate by 25-50 mg weekly; typical 100-200 mg/day; max 300 mg/day</td>
<td>MAOIs; alosetron, tizanidine (drug interactions)</td>
<td>Multiple drug interactions (CYP1A2, 2C19, 3A4 inhibitor); GI symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Mirtazapine (Remeron)</td>
<td>PO</td>
<td>Depression with poor appetite, weight loss, and insomnia</td>
<td>7.5 mg qHS; 15 mg qHS; 30 mg qHS :: PO :: :: Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating</td>
<td>MAOIs; angle-closure glaucoma</td>
<td>Weight gain (often desired in FTD); sedation; hyperlipidemia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Bupropion (Wellbutrin)</td>
<td>PO</td>
<td>Apathy-predominant FTD; depression; may help with motivation</td>
<td>100 mg BID; 150 mg SR daily; 150 mg SR BID; 300 mg XL daily :: PO :: :: Start 100 mg BID or 150 mg SR daily; titrate to 150 mg SR BID or 300 mg XL daily</td>
<td>Seizure disorder; bulimia/anorexia; concurrent MAOIs; abrupt alcohol withdrawal</td>
<td>Seizure risk (dose-related); insomnia; agitation (may worsen some patients)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Melatonin</td>
<td>PO</td>
<td>Sleep disturbance; circadian rhythm dysfunction; sundowning</td>
<td>3 mg qHS; 6 mg qHS; 9 mg qHS :: PO :: :: Start 3 mg qHS, 30 min before bed; may increase to 6-9 mg if needed</td>
<td>None significant</td>
<td>Daytime drowsiness; minimal side effects</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3c-second-linerefractory-behavioral-management">3C. Second-line/Refractory (Behavioral Management)<a class="headerlink" href="#3c-second-linerefractory-behavioral-management" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Quetiapine (Seroquel)</td>
<td>PO</td>
<td>Severe agitation/psychosis when non-pharmacologic and first-line fail</td>
<td>12.5 mg qHS; 25 mg qHS; 25 mg BID; 50 mg BID :: PO :: :: Start 12.5-25 mg qHS; titrate slowly (25 mg increments); keep dose as low as possible; max 200 mg/day</td>
<td>Black box: increased mortality in dementia; avoid in FTD-parkinsonism</td>
<td>Metabolic effects; sedation; falls; QTc; EPS</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Olanzapine</td>
<td>PO/IM</td>
<td>Severe agitation when other options fail; IM for acute crisis</td>
<td>2.5 mg daily; 5 mg daily; 2.5 mg IM; 5 mg IM :: PO/IM :: :: PO: Start 2.5 mg daily; increase slowly; max 10 mg; IM: 2.5-5 mg for acute crisis</td>
<td>Black box: increased mortality in dementia; diabetes; QT prolongation</td>
<td>Weight gain; metabolic syndrome; sedation; EPS</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Dextromethorphan/quinidine (Nuedexta)</td>
<td>PO</td>
<td>Pseudobulbar affect; emotional lability; pathological laughing/crying</td>
<td>20/10 mg daily; 20/10 mg BID :: PO :: :: Start 20/10 mg daily x 7 days; then 20/10 mg BID</td>
<td>QT prolongation; concurrent MAOIs; quinidine hypersensitivity; complete AV block</td>
<td>QTc; avoid in hepatic/renal impairment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Valproic acid</td>
<td>PO</td>
<td>Impulsivity; aggression; mood instability (off-label)</td>
<td>125 mg BID; 250 mg BID; 500 mg BID :: PO :: :: Start 125-250 mg BID; titrate to 500-1000 mg/day; monitor levels</td>
<td>Hepatic disease; urea cycle disorders; mitochondrial disorders</td>
<td>Valproate level, LFTs, CBC, ammonia; weight gain; tremor; thrombocytopenia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Memantine (Namenda)</td>
<td>PO</td>
<td>May help some behavioral symptoms; limited evidence</td>
<td>5 mg daily; 5 mg BID; 10 mg BID :: PO :: :: Start 5 mg daily; increase by 5 mg/week to 10 mg BID; evidence weak in FTD</td>
<td>Severe renal impairment (reduce dose)</td>
<td>Confusion, dizziness; generally well tolerated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Methylphenidate</td>
<td>PO</td>
<td>Severe apathy unresponsive to other treatments</td>
<td>2.5 mg BID; 5 mg BID; 10 mg BID :: PO :: :: Start 2.5-5 mg BID (morning and noon); titrate slowly; max 20 mg/day</td>
<td>Severe anxiety; cardiac arrhythmias; glaucoma; concurrent MAOIs</td>
<td>BP, HR; appetite; insomnia; agitation; abuse potential</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3d-treatments-to-avoid-in-ftd">3D. Treatments to AVOID in FTD<a class="headerlink" href="#3d-treatments-to-avoid-in-ftd" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Donepezil (Aricept)</td>
<td>PO</td>
<td>AVOID - May worsen behavioral symptoms in FTD</td>
<td>AVOID :: PO :: :: Do NOT use; cholinesterase inhibitors can worsen disinhibition, agitation, and behavioral symptoms in FTD</td>
<td>FTD diagnosis</td>
<td>Worsening behavior if inadvertently started</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rivastigmine (Exelon)</td>
<td>PO/TD</td>
<td>AVOID - May worsen behavioral symptoms in FTD</td>
<td>AVOID :: PO/TD :: :: Do NOT use; cholinesterase inhibitors not recommended in FTD; may cause paradoxical worsening</td>
<td>FTD diagnosis</td>
<td>Worsening behavior if inadvertently started</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Galantamine (Razadyne)</td>
<td>PO</td>
<td>AVOID - May worsen behavioral symptoms in FTD</td>
<td>AVOID :: PO :: :: Do NOT use; cholinesterase inhibitors contraindicated in FTD</td>
<td>FTD diagnosis</td>
<td>Worsening behavior if inadvertently started</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>Note on Antipsychotics:</strong> Use with extreme caution. Increased mortality risk in dementia; increased risk of EPS in FTD-parkinsonism; reserve for severe, refractory cases where safety is at risk.</p>
<hr />
<h3 id="3e-ftd-alsmotor-neuron-disease-overlap">3E. FTD-ALS/Motor Neuron Disease Overlap<a class="headerlink" href="#3e-ftd-alsmotor-neuron-disease-overlap" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Riluzole</td>
<td>PO</td>
<td>FTD with ALS overlap; may modestly slow MND progression</td>
<td>50 mg BID :: PO :: :: 50 mg PO BID; take 1 hour before or 2 hours after meals</td>
<td>Hepatic impairment; pregnancy</td>
<td>LFTs monthly x 3 months, then q3mo; neutropenia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Edaravone (Radicava)</td>
<td>IV/PO</td>
<td>FTD-ALS if early in disease course</td>
<td>60 mg IV daily x 14d; 10-day cycles :: IV/PO :: :: Initial: 60 mg IV daily x 14 days; maintenance: 60 mg IV daily x 10 days of 14-day cycles; oral formulation available</td>
<td>Hypersensitivity; sulfite allergy</td>
<td>Infusion reactions; hypersensitivity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sodium phenylbutyrate/taurursodiol (Relyvrio)</td>
<td>PO</td>
<td>FTD-ALS overlap; neuroprotective</td>
<td>3g/1g sachet BID :: PO :: :: One sachet dissolved in water BID; titrate over 3 weeks to full dose</td>
<td>Hepatic impairment</td>
<td>GI symptoms (diarrhea, nausea); gallbladder disorders</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Behavioral/cognitive neurology for diagnosis confirmation, FTD subtype classification, and treatment guidance</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Neuropsychology for comprehensive cognitive testing to establish baseline, characterize deficits, and track progression</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Genetic counseling for all patients with suspected FTD given high heritability (30-50% familial); discuss testing implications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Speech-language pathology for language variant PPA evaluation, communication strategies, and swallowing assessment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Geriatric psychiatry for complex behavioral management and psychotropic medication optimization</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Social work for caregiver support resources, community services, respite care, and long-term care planning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Occupational therapy for ADL assessment, cognitive strategies, home safety evaluation, and activity structuring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Physical therapy for fall prevention, mobility assessment, and exercise program particularly if motor features present</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Palliative care for symptom management and goals of care discussions, especially with advanced disease or ALS overlap</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Neuromuscular specialist if motor neuron disease features (weakness, fasciculations, bulbar symptoms) present</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Elder law attorney for advance directives, healthcare proxy, conservatorship, and financial planning while capacity exists</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Return immediately if sudden worsening of behavior, new weakness, difficulty breathing, or inability to swallow safely</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Complete advance directives (living will, healthcare proxy, POLST) while patient retains capacity; FTD can progress rapidly</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Designate durable power of attorney for healthcare AND finances early as judgment may be impaired before memory</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not drive; FTD impairs judgment, impulse control, and decision-making even if memory appears intact</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Remove access to weapons, power tools, and dangerous equipment due to impaired judgment and safety awareness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Supervise financial decisions; patients with FTD are vulnerable to fraud, impulsive spending, and poor judgment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Secure medications to prevent accidental or intentional overdose; use locked medication storage</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Monitor for wandering; consider GPS tracking devices and door alarms as disease progresses</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Report diagnosis to DMV per state requirements; most states require physician reporting for unsafe drivers</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Genetic testing results have implications for family members; discuss with genetic counselor before testing</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Structured daily routine with consistent schedule reduces anxiety and behavioral symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Regular physical activity (walking, supervised exercise) improves mood and maintains function</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Simplified communication using short sentences, yes/no questions, and visual cues for PPA variants</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid overstimulation; reduce noise, crowds, and complex environments that trigger agitation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Caregiver education through AFTD (Association for Frontotemporal Degeneration) resources and support groups</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Respite care for caregivers to prevent burnout; FTD caregiving is particularly demanding due to behavioral symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Address hyperorality and dietary changes with portion control, healthy snack availability, and locked food storage if needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Safe environment modifications: remove fall hazards, lock cabinets with dangerous items, install stove knob covers</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>One-to-one supervision may be needed for safety; consider adult day programs or in-home care</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Smoking cessation and alcohol avoidance to prevent additional brain injury and drug interactions</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="section-b-reference">SECTION B: REFERENCE<a class="headerlink" href="#section-b-reference" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alzheimer's disease</td>
<td>Memory impairment prominent early; episodic memory loss; posterior cortical atrophy pattern</td>
<td>CSF Aβ42 low, p-tau elevated; amyloid PET positive; temporal-parietal atrophy on MRI</td>
</tr>
<tr>
<td>Dementia with Lewy bodies</td>
<td>Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition</td>
<td>DaTscan reduced; RBD on sleep study; better response to cholinesterase inhibitors</td>
</tr>
<tr>
<td>Primary psychiatric disorder</td>
<td>Onset often younger; personal/family psychiatric history; may have insight; responds to treatment</td>
<td>Normal MRI; normal FDG-PET; improvement with psychiatric treatment</td>
</tr>
<tr>
<td>Huntington's disease</td>
<td>Chorea; family history (autosomal dominant); psychiatric symptoms precede motor</td>
<td>CAG repeat expansion; caudate atrophy on MRI</td>
</tr>
<tr>
<td>Progressive supranuclear palsy (PSP)</td>
<td>Vertical gaze palsy; axial rigidity; early falls; frontal features</td>
<td>"Hummingbird sign" on MRI; poor levodopa response</td>
</tr>
<tr>
<td>Corticobasal syndrome (CBS)</td>
<td>Asymmetric apraxia; alien limb; cortical sensory loss; dystonia</td>
<td>Asymmetric atrophy; may have FTD overlap</td>
</tr>
<tr>
<td>Creutzfeldt-Jakob disease</td>
<td>Rapid progression (weeks-months); myoclonus; ataxia; startle</td>
<td>MRI DWI ribboning; EEG periodic discharges; CSF RT-QuIC positive</td>
</tr>
<tr>
<td>Autoimmune encephalitis</td>
<td>Subacute onset; seizures; psychiatric features; often younger</td>
<td>Autoantibody panel positive; MRI limbic changes; CSF inflammation</td>
</tr>
<tr>
<td>Normal pressure hydrocephalus</td>
<td>Gait disturbance predominant; urinary incontinence; magnetic gait</td>
<td>MRI ventriculomegaly out of proportion to atrophy; large-volume LP improvement</td>
</tr>
<tr>
<td>Vascular dementia</td>
<td>Stepwise decline; vascular risk factors; focal deficits</td>
<td>Extensive white matter disease and strategic infarcts on MRI</td>
</tr>
<tr>
<td>Medication/substance-induced</td>
<td>Temporal relationship to drug exposure; anticholinergics, sedatives common culprits</td>
<td>Medication reconciliation; improvement with discontinuation</td>
</tr>
<tr>
<td>Late-onset bipolar disorder</td>
<td>Episodic mood symptoms; family history; intact cognition between episodes</td>
<td>Normal neuroimaging; psychiatric evaluation; treatment response</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cognitive testing (MoCA, MMSE, or FTLD-specific battery)</td>
<td>Every 6-12 months</td>
<td>Document trajectory; identify rapid decline</td>
<td>Adjust care level; medication review; genetics if rapid</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Frontal assessment battery (FAB)</td>
<td>Every 6-12 months</td>
<td>Track executive function specific to FTD</td>
<td>Increase supervision; safety planning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Functional status (ADL/IADL, FBI, CBI)</td>
<td>Every 6 months</td>
<td>Monitor independence and safety</td>
<td>Increase caregiver support; consider placement</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Behavioral assessment (NPI-Q, FBI)</td>
<td>Each visit</td>
<td>Quantify behavioral symptoms and treatment response</td>
<td>Adjust medications; non-pharmacologic strategies</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Motor function (if FTD-ALS)</td>
<td>Every 3-6 months</td>
<td>FVC, ALSFRS-R for motor progression</td>
<td>Respiratory support; PT/OT; feeding tube discussion</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Weight</td>
<td>Each visit</td>
<td>Stable; monitor for hyperorality weight gain OR wasting</td>
<td>Nutritional consult; address hyperphagia or dysphagia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Swallowing function</td>
<td>Every 6-12 months or if symptoms</td>
<td>Safe oral intake</td>
<td>Speech therapy; diet modification; feeding tube if needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Caregiver burden (Zarit Burden Interview)</td>
<td>Every 6-12 months</td>
<td>Early identification of burnout</td>
<td>Respite care; support groups; social work</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Safety assessment</td>
<td>Each visit</td>
<td>No harm to self or others; safe environment</td>
<td>Increase supervision; remove hazards; consider placement</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ECG (if on QT-prolonging medications)</td>
<td>Baseline; with dose changes</td>
<td>QTc &lt;470 ms (men), &lt;480 ms (women)</td>
<td>Reduce dose or switch medication</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>LFTs (if on valproic acid or riluzole)</td>
<td>Monthly x 3, then q3mo</td>
<td>Normal transaminases</td>
<td>Reduce or discontinue if &gt;3x ULN</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discharge home</td>
<td>Behavioral crisis resolved; safe environment; adequate caregiver supervision; outpatient follow-up arranged; medications optimized</td>
</tr>
<tr>
<td>Admit to floor</td>
<td>Severe behavioral disturbance unsafe for home; medical workup needed; medication adjustment requiring monitoring; caregiver unable to manage</td>
</tr>
<tr>
<td>Admit to psychiatry</td>
<td>Danger to self or others; severe aggression; psychotic features; requires locked unit for safety</td>
</tr>
<tr>
<td>Memory care/Long-term care</td>
<td>Progressive decline; wandering risk; 24-hour supervision needed; caregiver unable to provide safe care</td>
</tr>
<tr>
<td>Hospice</td>
<td>End-stage FTD; minimal responsiveness; recurrent aspiration; weight loss; goals focused on comfort; FVC &lt;50% in FTD-ALS</td>
</tr>
<tr>
<td>Outpatient follow-up</td>
<td>Neurology/cognitive neurology every 3-6 months; more frequent if on psychotropics or rapid progression; genetics follow-up after testing</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diagnostic criteria for bvFTD (International Consensus)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/21824939/">Rascovsky et al. Brain 2011</a></td>
</tr>
<tr>
<td>Diagnostic criteria for PPA variants</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/21325651/">Gorno-Tempini et al. Neurology 2011</a></td>
</tr>
<tr>
<td>SSRIs for behavioral symptoms in FTD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/22687702/">Herrmann et al. J Clin Psychiatry 2012</a></td>
</tr>
<tr>
<td>Trazodone for FTD behavioral symptoms</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15178936/">Lebert et al. Dement Geriatr Cogn Disord 2004</a></td>
</tr>
<tr>
<td>Cholinesterase inhibitors not recommended in FTD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/17804830/">Mendez et al. Am J Alzheimers Dis Other Demen 2007</a></td>
</tr>
<tr>
<td>Antipsychotic mortality risk in dementia</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16219884/">Schneider et al. JAMA 2005</a></td>
</tr>
<tr>
<td>C9orf72 as most common genetic cause of FTD/ALS</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/21944778/">DeJesus-Hernandez et al. Neuron 2011</a>; <a href="https://pubmed.ncbi.nlm.nih.gov/21944779/">Renton et al. Neuron 2011</a></td>
</tr>
<tr>
<td>MAPT and GRN mutations in familial FTD</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/19345567/">Rohrer et al. Lancet Neurol 2009</a></td>
</tr>
<tr>
<td>FDG-PET in FTD diagnosis</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/17315189/">Foster et al. Ann Neurol 2007</a></td>
</tr>
<tr>
<td>CSF NfL as prognostic biomarker in FTD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27164711/">Rohrer et al. Neurology 2016</a></td>
</tr>
<tr>
<td>Memantine limited efficacy in FTD</td>
<td>Class II, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/23684085/">Boxer et al. Lancet Neurol 2013</a></td>
</tr>
<tr>
<td>FTD-ALS continuum</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27083437/">Burrell et al. Lancet Neurol 2016</a></td>
</tr>
<tr>
<td>Serum progranulin as GRN mutation screen</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/19359499/">Finch et al. J Mol Diagn 2009</a></td>
</tr>
<tr>
<td>Practice guidelines for FTD management</td>
<td>Class III, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/34341099/">Tsai et al. Neurology 2021</a></td>
</tr>
<tr>
<td>Riluzole in ALS</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/22419334/">Miller et al. Cochrane 2012</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 27, 2026)</strong>
- Initial template creation
- International consensus diagnostic criteria for bvFTD and PPA variants
- Comprehensive genetic evaluation (C9orf72, MAPT, GRN)
- SSRIs and trazodone as first-line behavioral treatments
- Explicit guidance to AVOID cholinesterase inhibitors
- FTD-ALS overlap section with riluzole and edaravone
- Caregiver support and safety planning emphasis
- Structured dosing format for order sentence generation
- PubMed-linked citations</p>
<hr />
<h2 id="appendix-a-ftd-clinical-variants">APPENDIX A: FTD Clinical Variants<a class="headerlink" href="#appendix-a-ftd-clinical-variants" title="Permanent link">&para;</a></h2>
<h3 id="behavioral-variant-ftd-bvftd">Behavioral Variant FTD (bvFTD)<a class="headerlink" href="#behavioral-variant-ftd-bvftd" title="Permanent link">&para;</a></h3>
<p><strong>Core Features (International Consensus Criteria - Rascovsky 2011):</strong></p>
<p>Early behavioral disinhibition (at least one of):
- Socially inappropriate behavior
- Loss of manners or decorum
- Impulsive, rash, or careless actions</p>
<p>Early apathy or inertia (at least one of):
- Loss of motivation or drive
- Emotional blunting
- Withdrawal from activities</p>
<p>Early loss of sympathy or empathy (at least one of):
- Diminished response to others' needs
- Diminished social interest, warmth
- Personal coldness</p>
<p>Early perseverative, stereotyped, or compulsive/ritualistic behavior (at least one of):
- Simple repetitive movements
- Complex compulsive behaviors
- Stereotypy of speech</p>
<p>Hyperorality and dietary changes (at least one of):
- Altered food preferences (especially sweets)
- Binge eating or increased consumption
- Oral exploration of inedible objects</p>
<p>Neuropsychological profile:
- Executive deficits
- Relative sparing of episodic memory
- Relative sparing of visuospatial skills</p>
<p><strong>Possible bvFTD:</strong> 3 of 6 features
<strong>Probable bvFTD:</strong> Possible + functional decline + characteristic imaging
<strong>Definite bvFTD:</strong> Histopathological or pathogenic mutation confirmation</p>
<hr />
<h3 id="semantic-variant-ppa-svppa">Semantic Variant PPA (svPPA)<a class="headerlink" href="#semantic-variant-ppa-svppa" title="Permanent link">&para;</a></h3>
<p><strong>Core Features:</strong>
- Impaired confrontation naming
- Impaired single-word comprehension</p>
<p><strong>Supportive Features (3 of 4 required):</strong>
- Impaired object knowledge
- Surface dyslexia or dysgraphia
- Spared repetition
- Spared speech production (grammar and motor speech)</p>
<p><strong>Imaging:</strong> Anterior temporal atrophy (typically left &gt; right)</p>
<hr />
<h3 id="nonfluentagrammatic-variant-ppa-nfvppa">Nonfluent/Agrammatic Variant PPA (nfvPPA)<a class="headerlink" href="#nonfluentagrammatic-variant-ppa-nfvppa" title="Permanent link">&para;</a></h3>
<p><strong>Core Features (at least one):</strong>
- Agrammatism in language production
- Effortful, halting speech with inconsistent speech sound errors (apraxia of speech)</p>
<p><strong>Supportive Features (2 of 3 required):</strong>
- Impaired comprehension of syntactically complex sentences
- Spared single-word comprehension
- Spared object knowledge</p>
<p><strong>Imaging:</strong> Left posterior fronto-insular atrophy</p>
<hr />
<h2 id="appendix-b-genetic-evaluation-guide">APPENDIX B: Genetic Evaluation Guide<a class="headerlink" href="#appendix-b-genetic-evaluation-guide" title="Permanent link">&para;</a></h2>
<h3 id="when-to-consider-genetic-testing">When to Consider Genetic Testing<a class="headerlink" href="#when-to-consider-genetic-testing" title="Permanent link">&para;</a></h3>
<p><strong>Strongly Consider Testing:</strong>
- Family history of FTD, ALS, or unspecified dementia in first-degree relative
- Age of onset &lt;60 years
- FTD-ALS phenotype
- Known family mutation</p>
<p><strong>Consider Testing:</strong>
- Any FTD diagnosis (30-50% have genetic component)
- Research participation interest
- Family planning implications for children</p>
<h3 id="major-ftd-genes">Major FTD Genes<a class="headerlink" href="#major-ftd-genes" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Protein</th>
<th>Frequency</th>
<th>Phenotype</th>
<th>Pathology</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>C9orf72</strong></td>
<td>None (repeat expansion)</td>
<td>25-40% of familial</td>
<td>bvFTD, ALS, FTD-ALS, psychosis</td>
<td>TDP-43, p62 inclusions</td>
</tr>
<tr>
<td><strong>GRN</strong></td>
<td>Progranulin</td>
<td>15-25% of familial</td>
<td>bvFTD (asymmetric), PPA, CBS</td>
<td>TDP-43 type A</td>
</tr>
<tr>
<td><strong>MAPT</strong></td>
<td>Tau</td>
<td>10-20% of familial</td>
<td>bvFTD, parkinsonism, PSP-like</td>
<td>Tau pathology</td>
</tr>
<tr>
<td><strong>TARDBP</strong></td>
<td>TDP-43</td>
<td>&lt;5%</td>
<td>ALS, FTD-ALS</td>
<td>TDP-43</td>
</tr>
<tr>
<td><strong>VCP</strong></td>
<td>Valosin-containing protein</td>
<td>&lt;5%</td>
<td>IBM, Paget's, FTD</td>
<td>TDP-43</td>
</tr>
<tr>
<td><strong>FUS</strong></td>
<td>FUS</td>
<td>&lt;1%</td>
<td>ALS, FTD</td>
<td>FUS inclusions</td>
</tr>
</tbody>
</table>
<h3 id="progranulin-screening">Progranulin Screening<a class="headerlink" href="#progranulin-screening" title="Permanent link">&para;</a></h3>
<p>Serum progranulin level can screen for GRN mutations:
- <strong>Normal:</strong> &gt;100 ng/mL (varies by assay)
- <strong>Low:</strong> &lt;100 ng/mL suggests GRN mutation; confirm with gene sequencing</p>
<h3 id="c9orf72-interpretation">C9orf72 Interpretation<a class="headerlink" href="#c9orf72-interpretation" title="Permanent link">&para;</a></h3>
<ul>
<li><strong>Normal:</strong> &lt;30 hexanucleotide repeats</li>
<li><strong>Pathogenic:</strong> &gt;30 repeats (typically hundreds to thousands)</li>
<li><strong>Intermediate:</strong> 20-30 repeats (clinical significance unclear)</li>
</ul>
<hr />
<h2 id="appendix-c-safety-and-supervision-planning-checklist">APPENDIX C: Safety and Supervision Planning Checklist<a class="headerlink" href="#appendix-c-safety-and-supervision-planning-checklist" title="Permanent link">&para;</a></h2>
<h3 id="immediate-safety-all-ftd-patients">Immediate Safety (All FTD Patients)<a class="headerlink" href="#immediate-safety-all-ftd-patients" title="Permanent link">&para;</a></h3>
<ul class="task-list">
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Driving cessation discussed and documented</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Weapons removed from home</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Medications secured (locked storage)</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Financial oversight arranged</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Stove/appliance safety (knob covers, auto-shutoff)</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Door alarms/locks for wandering risk</li>
</ul>
<h3 id="advance-planning">Advance Planning<a class="headerlink" href="#advance-planning" title="Permanent link">&para;</a></h3>
<ul class="task-list">
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Healthcare power of attorney designated</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Durable financial power of attorney designated</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Living will/advance directive completed</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> POLST form if appropriate</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Long-term care financing discussed</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Genetic counseling offered to family</li>
</ul>
<h3 id="caregiver-support">Caregiver Support<a class="headerlink" href="#caregiver-support" title="Permanent link">&para;</a></h3>
<ul class="task-list">
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> AFTD (theaftd.org) resources provided</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Local support group identified</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Respite care options discussed</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Adult day program referral if appropriate</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Home health aide evaluation</li>
<li class="task-list-item"><label class="task-list-control"><input type="checkbox" disabled/><span class="task-list-indicator"></span></label> Social work consultation</li>
</ul>
<h3 id="monitoring-red-flags">Monitoring Red Flags<a class="headerlink" href="#monitoring-red-flags" title="Permanent link">&para;</a></h3>
<p><strong>Contact Provider If:</strong>
- New or worsening aggression
- Suicidal statements or self-harm behavior
- Inability to recognize caregivers
- Falls with injury
- Significant weight loss or gain
- Swallowing difficulties
- New weakness (FTD-ALS concern)
- Caregiver exhaustion/burnout</p>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>